Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 47.5621.21-60.59-243.82-6.83

What is the latest EV/EBIT ratio of ORCHID PHARMA ?

The latest EV/EBIT ratio of ORCHID PHARMA is 47.56 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202447.56
Mar202321.21
Mar2022-60.59
Mar2021-243.82
Mar2020-6.83

How is EV/EBIT of ORCHID PHARMA Trending?

Years EV/EBIT % Change
Mar2024 47.56
124.23
Mar2023 21.21
Positive
Mar2022 -60.59
Negative
Mar2021 -243.82
Negative
Mar2020 -6.83 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/EBIT ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹4,661.6 Cr -1.2% -38.6% -14.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,569.0 Cr 2.8% -7.5% 2.3% Stock Analytics
DIVIS LABORATORIES ₹146,318.0 Cr -0.2% -9.9% 60.4% Stock Analytics
CIPLA ₹118,110.0 Cr 4.4% -0.6% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,926.0 Cr 4.8% -2.9% 15.4% Stock Analytics
DR REDDYS LABORATORIES ₹93,471.5 Cr NA -9.4% -10.2% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-1.2%

-38.6%

-14.7%

SENSEX

1.4%

-5.3%

0.3%


You may also like the below Video Courses